Note 8 – Subsequent Events

Except as noted below, there were no material subsequent events that required recognition or additional disclosure in these condensed consolidated financial statements.

On July 23, 2025, the Company entered into a securities purchase agreement in relation to a registered direct public offering with certain purchasers, under a Shelf Registration Statement, of $1.74 million of the Company’s securities, consisting of (i) 414,331 shares of Common Stock, par value $0.0001 per share and 559,910 pre-funded warrants to acquire shares of Common Stock; and (ii) in a concurrent private placement, 974,241 warrants to acquire shares of Common Stock at the exercise price of $1.66 per share, at the price of $1.786 for each one share of Common Stock or Pre-Funded Warrant, and Common Warrant. The offering closed on July 25, 2025.

On July 25, 2025, the Company entered into a securities purchase agreement with certain accredited individual and institutional investors for the issuance and sale in a private placement of (i) 641,190 shares of the Company’s common stock, par value $0.0001, (ii) pre-funded warrants to purchase up to 103,490 shares of the Company’s Common Stock at an exercise price of $0.001 per share, (iii) common warrants to purchase up to744,680 shares of the Company’s Common Stock, at an exercise price of $1.52 per share of Common Stock, at the price of $1.645 for each one share of Common Stock, Pre-Funded Warrant, and Common Warrant purchased pursuant to the Purchase Agreement. Net proceeds to the Company from the offering were approximately $1.1 million. The offering closed on July 31, 2025.

On August 4, 2025, the Company’s board of directors appointed Nancy Davis as a member of the Board effective as of August 4, 2025. Ms. Davis will serve for a term expiring at the 2026 annual meeting of stockholders.